The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.
Related Posts
Stocks making the biggest moves midday: Krispy Kreme, Chegg, Zoom Communications and more
These are the stocks posting the largest moves in midday trading.
Constitutional amendment to allow Trump third term introduced in the House
President Donald Trump has hinted at the possibility of somehow serving a third term in office.
Trump Defense pick Hegseth investigated in 2017 for alleged sex assault; no charges filed
President-elect Donald Trump surprised some Republican senators by picking former Fox News host Pete Hegseth to lead the Pentagon.